- ELOX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Eloxx Pharmaceuticals (ELOX) S-3Shelf registration
Filed: 16 Nov 18, 4:17pm
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the reference to our firm under the caption “Experts” in the Registration Statement (Form S-3) and related Prospectus of Eloxx Pharmaceuticals, Inc. and to the incorporation by reference therein of our report dated March 16, 2018, with respect to the consolidated financial statements of Eloxx Pharmaceuticals, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2017, filed with the Securities and Exchange Commission.
/s/ Kost Forer Gabbay & Kasierer | |
Tel-Aviv | Kost Forer Gabbay & Kasierer |
November 16, 2018 | A Member of Ernst & Young Global |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.